<DOC>
	<DOCNO>NCT00774189</DOCNO>
	<brief_summary>The objective study compare single-dose oral bioavailability Clarithromycin 250 mg tablet Ranbaxy Laboratories Biaxin 250 mg tablet Abbott Laboratories healthy , adult , human subject fast condition</brief_summary>
	<brief_title>Bioequivalence Study Clarithromycin 250mg Tablets Under Fasting Conditions</brief_title>
	<detailed_description>This open label , balance , randomize , two-treatment , two-period , two-sequence , single-dose , crossover bioavailability study plan 32 healthy , adult , human subject fast condition . 31 subject complete period study . Both period separate washout twelve day The study conduct 32 healthy , adult , human subject fast condition . 31 subject complete period study</detailed_description>
	<mesh_term>Clarithromycin</mesh_term>
	<criteria>1 . Be age range 1845 year . 2 . Be neither overweight underweight his/her height per Life Insurance Corporation India height/weight chart nonmedical case . 3 . Have voluntarily give write informed consent participate study . 4 . Be normal health determine medical history physical 5 . Examination subject perform .within 14 day prior commencement study . 6 . If female : Of childbearing potential , practice acceptable method birth control duration study judge investigator ( ) , condom , foam , jelly , diaphragm , intrauterine device ( IUD ) , abstinence ; or~ Is postmenopausal least 1 year ; Is surgically sterile bilateral tubal ligation , bilateral oophorectomy , hysterectomy ) 1 . History allergy clarithromycin , erythromycin relate macrolides 2 . Any evidence organ dysfunction clinically significant deviation normal , physical clinical determination . 3 . Presence disease marker HIV 1 2 , Hepatitis B C viruses syphilis infection . 4 . Female volunteer demonstrate positive pregnancy screen . 5 . Female volunteer currently breastfeed . 6 . Presence value ' clinically significantly different normal reference range haemoglobin , total white blood cell count , differential WBC count platelet count 7 . Positive urinary screen test drug abuse ( opiates cannabinoids 8 . Presence value significantly different normal.reference range ( define Appendix 5 ) se rum creatinine , blood urea nitrogen serum aspartate aminotransferase ( AST ) , serum alanine aminotranferase ( ALT ) , serum alkaline phosphatase , serum billrubin , plasma glucose serum cholesterol 9 . Clinically abnormal chemical microscopic examination urine define presence RBC , WBC ( &gt; 4/HPF ) , epithelial cell ( &gt; 4/HPF ) , glucose , ( positive ) protein ( positive ) . 10 . History serious gastrointestinal , hepatic , renal , cardiovascular , pulmonary , neurological hematological disease , diabetes glaucoma . 11 . History psychiatric illness . may impair ability provide write informed consent . 12 . Regular smoker smoke 10 cigarette daily difficulty abstain smoke duration study period . 13 . History drug dependence excessive alcohol intake habitual basis 2 unit alcoholic beverage per day ( 1 'unit equivalent half pint beer 1 glass wine 1 measure spirit ) difficulty abstain duration study period . 14 . Use enzyme modifying drug within 30 day prior Day I study 15 . Participation clinical trial within 12 week preceeding day 1 study 16 . Subjects , completion study , would donate and/or lose 350 mL blood past 3 month</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>Bioequivalence clarithromycin 250mg tablet fast</keyword>
</DOC>